Literature DB >> 19728850

Clinical relevance of circulating midkine in ulcerative colitis.

Malgorzata Krzystek-Korpacka1, Katarzyna Neubauer, Malgorzata Matusiewicz.   

Abstract

BACKGROUND: Non-invasive biochemical markers are needed to support the diagnosis of ulcerative colitis (UC), an incurable disease of unknown pathology. Midkine is an angiogenic cytokine, chemotactic towards neutrophils and macrophages, and a T-regulatory cell suppressor.
METHODS: Serum midkine was measured immunoenzymatically in 93 UC patients and 108 healthy subjects, and evaluated with respect to disease status, endoscopic, inflammatory and angiogenic activity. The diagnostic value of midkine was compared to C-reactive protein (CRP) using receiver operating characteristics (ROC) analysis.
RESULTS: Midkine was higher (p<0.0001) in inactive (199 ng/L) and active UC (351 ng/L) compared with controls (93 ng/L), and reflected disease activity (r=0.427, p<0.001). Midkine was correlated with CRP, erythrocyte sedimentation rate (ESR), leukocytes, platelets, interleukin-6, paraoxonase-1, albumin, transferrin, iron, hemoglobin, and hematocrit. Midkine correlated with angiogenic factors: vascular endothelial growth factor-A and platelet-derived growth factor-BB. As a marker of UC, midkine showed a diagnostic accuracy of 85%, sensitivity of 72%, specificity of 82%, whereas CRP showed 83%, 65% and 91%, respectively. As a marker of active UC, midkine showed a diagnostic accuracy of 87%, sensitivity of 84%, specificity of 75%, whereas CRP showed 75%, 63% and 83%, respectively. Combined assessment of midkine and CRP improved sensitivity but substantially decreased specificity.
CONCLUSIONS: UC is associated with increased circulating midkine, which corresponds with clinical, endoscopic, inflammatory and angiogenic activity, and anemia. Performance of midkine as a marker of UC or active UC was comparable to that of CRP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19728850     DOI: 10.1515/CCLM.2009.248

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  12 in total

Review 1.  Role of the endothelium in inflammatory bowel diseases.

Authors:  Walter E Cromer; J Michael Mathis; Daniel N Granger; Ganta V Chaitanya; J Steven Alexander
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 2.  C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis.

Authors:  Mahmoud H Mosli; Guangyong Zou; Sushil K Garg; Sean G Feagan; John K MacDonald; Nilesh Chande; William J Sandborn; Brian G Feagan
Journal:  Am J Gastroenterol       Date:  2015-05-12       Impact factor: 10.864

3.  Active and Repressive Chromatin-Associated Proteome after MPA Treatment and the Role of Midkine in Epithelial Monolayer Permeability.

Authors:  Niamat Khan; Christof Lenz; Lutz Binder; Dasaradha Venkata Krishna Pantakani; Abdul R Asif
Journal:  Int J Mol Sci       Date:  2016-04-20       Impact factor: 5.923

4.  The inflammatory phase of fracture healing is influenced by oestrogen status in mice.

Authors:  Melanie Haffner-Luntzer; Verena Fischer; Katja Prystaz; Astrid Liedert; Anita Ignatius
Journal:  Eur J Med Res       Date:  2017-07-06       Impact factor: 2.175

5.  Elevated plasma midkine and pleiotrophin levels in patients with systemic lupus erythematosus.

Authors:  Guo-Cui Wu; Hui Yuan; Hai-Feng Pan; Dong-Qing Ye
Journal:  Oncotarget       Date:  2017-06-20

6.  Peripheral Lymphocytes of Patients with Inflammatory Bowel Disease Have Altered Concentrations of Key Apoptosis Players: Preliminary Results.

Authors:  Katarzyna Neubauer; Barbara Woźniak-Stolarska; Małgorzata Krzystek-Korpacka
Journal:  Biomed Res Int       Date:  2018-11-01       Impact factor: 3.411

7.  Serum Midkine Levels in Systemic Lupus Erythematosus.

Authors:  Blondina Marpaung; Andi Raga Ginting; Ok Moehad Sjah
Journal:  Open Access Maced J Med Sci       Date:  2018-08-14

8.  Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseases.

Authors:  Malgorzata Matusiewicz; Katarzyna Neubauer; Magdalena Mierzchala-Pasierb; Andrzej Gamian; Malgorzata Krzystek-Korpacka
Journal:  Dis Markers       Date:  2014-03-31       Impact factor: 3.434

9.  Midkine, a potential link between obesity and insulin resistance.

Authors:  Nengguang Fan; Haiyan Sun; Yifei Wang; Lijuan Zhang; Zhenhua Xia; Liang Peng; Yanqiang Hou; Weiqin Shen; Rui Liu; Yongde Peng
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

10.  Midkine level may be used as a noninvasive biomarker in Crohn’s disease

Authors:  Murat Kekilli; Alpaslan Tanoğlu; Fatih Karaahmet; Zeynal Doğan; Murat Can; Abdurrahim Sayilir; Başak Çakal; Tolga Düzenli; Yavuz Beyazit
Journal:  Turk J Med Sci       Date:  2020-04-09       Impact factor: 0.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.